| abstract |
The present disclosure provides a novel solid state form of a plastienolide pyridine compound, a composition comprising at least one such solid state form, and a method of making and using the solid state form. The novel solid state forms of the Pladienolide Pyridine Compounds may be useful in the treatment of cancer, such as, for example, splenocytes and agents that are known to be useful as agents that target mutants therein. |